Tag Archive

Creality 3D Technology Makes Historic Debut on Hong Kong Stock Exchange

By ChinaPulse.com

Creality 3D Technology Co., Ltd., a global leader in consumer 3D printing, marked a significant milestone by becoming the first consumer 3D printing company to be listed on the Main Board of The Stock Exchange of Hong Kong Limited.…
Source

Creality 3D Technology Makes Historic Debut on Hong Kong Stock Exchange

By ChinaPulse.com

Creality 3D Technology Co., Ltd., a global leader in consumer 3D printing, marked a significant milestone by becoming the first consumer 3D printing company to be listed on the Main Board of The Stock Exchange of Hong Kong Limited.…
Source

Exploring Barcelona’s ‘Future Factory’ Reveals Southern Europe’s Industrial Innovation

By ChinaPulse.com

Barcelona’s Zona Franca, established in 1916, serves as a hub for industrial transformation in Catalonia, showcasing key technologies like robotics, AI, and IoT. The area, located just 15 minutes south of downtown Barcelona, is adjacent to one of…

Lupeng Pharmaceutical Ventures into Hong Kong Stock Exchange: Can Antimicrobial Resistance Inhibitors Shape an 18A New Tale?

By ChinaPulse.com

Lupeng Pharmaceutical, a Guangzhou-based company, is making its second attempt at a mainboard IPO on the Hong Kong Stock Exchange. The company’s key asset, LP-168, a “covalent + non-covalent” dual mechanism BTK inhibitor, has entered …

Lupeng Pharmaceutical Ventures into Hong Kong Stock Exchange: Can Antimicrobial Resistance Inhibitors Shape an 18A New Tale?

By ChinaPulse.com

Lupeng Pharmaceutical, a Guangzhou-based company, is making its second attempt at a mainboard IPO on the Hong Kong Stock Exchange. The company’s key asset, LP-168, a “covalent + non-covalent” dual mechanism BTK inhibitor, has entered …

Lupeng Pharmaceutical Ventures into Hong Kong Stock Exchange: Can Antimicrobial Resistance Inhibitors Shape an 18A New Tale?

By ChinaPulse.com

Lupeng Pharmaceutical, a Guangzhou-based company, is making its second attempt at a mainboard IPO on the Hong Kong Stock Exchange. The company’s key asset, LP-168, a “covalent + non-covalent” dual mechanism BTK inhibitor, has entered …

Lupeng Pharmaceutical Ventures into Hong Kong Stock Exchange: Can Antimicrobial Resistance Inhibitors Shape an 18A New Tale?

By ChinaPulse.com

Lupeng Pharmaceutical, a Guangzhou-based company, is making its second attempt at a mainboard IPO on the Hong Kong Stock Exchange. The company’s key asset, LP-168, a “covalent + non-covalent” dual mechanism BTK inhibitor, has entered …

Lupeng Pharmaceutical Ventures into Hong Kong Stock Exchange: Can Antimicrobial Resistance Inhibitors Shape an 18A New Tale?

By ChinaPulse.com

Lupeng Pharmaceutical, a Guangzhou-based company, is making its second attempt at a mainboard IPO on the Hong Kong Stock Exchange. The company’s key asset, LP-168, a “covalent + non-covalent” dual mechanism BTK inhibitor, has entered …

4th CISCE Expands International Participation and Global Reach

By ChinaPulse.com

Australia Named Guest Country of Honor for the First Time; French and Italian Regions Debut as International Guest Provinces
BEIJING, May 29, 2026 /PRNewswire/ — The 4th China Interna…

Doping in Las Vegas: My Trip to the Enhanced Games

By ChinaPulse.com

Business Insider tells the innovative stories you want to know